Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth

Molecular Cancer Therapeutics
Karissa L GableJack F Youngren

Abstract

In breast and certain other cancers, receptor tyrosine kinases, including the insulin-like growth factor I receptor (IGF-IR), play an important role in promoting the oncogenic process. The IGF-IR is therefore an important target for developing new anti-breast cancer therapies. An initial screening of a chemical library against the IGF-IR in breast cancer cells identified a diaryl urea compound as a potent inhibitor of IGF-IR signaling. This class of compounds has not been studied as inhibitors of the IGF-IR. We studied the effectiveness of one diaryl urea compound, PQ401, at antagonizing IGF-IR signaling and inhibiting breast cancer cell growth in culture and in vivo. PQ401 inhibited autophosphorylation of the IGF-IR in cultured human MCF-7 cells with an IC50 of 12 micromol/L and autophosphorylation of the isolated kinase domain of the IGF-IR with an IC50 <1 micromol/L. In addition, PQ401 inhibited the growth of cultured breast cancer cells in serum at 10 micromol/L. PQ401 was even more effective at inhibiting IGF-I-stimulated growth of MCF-7 cells (IC50, 6 micromol/L). Treatment of MCF-7 cells with PQ401 was associated with a decrease in IGF-I-mediated signaling through the Akt antiapoptotic pathway. Twenty-four hours of treat...Continue Reading

References

Sep 1, 1992·Metabolism: Clinical and Experimental·G WeckbeckerC Bruns
Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·C T GuyW J Muller
Nov 1, 1989·The Journal of Clinical Investigation·C L ArteagaC K Osborne
Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·D PragerS Melmed
Mar 1, 1994·Molecular and Cellular Endocrinology·A V LeeR J King
Oct 1, 1995·Endocrine Reviews·R B Dickson, M E Lippman
Sep 1, 1996·Carcinogenesis·G ReighS Ninomiya
Jul 29, 1998·International Journal of Cancer. Journal International Du Cancer·M MüllerK Wiechen
Dec 2, 1999·Experimental Cell Research·R Baserga
May 3, 2000·Journal of Mammary Gland Biology and Neoplasia·E Surmacz
Dec 22, 2000·Biochemistry·G BlumA Levitzki
Mar 16, 2002·Nature Structural Biology·Christopher PargellisJohn Regan
Jun 28, 2002·Journal of Medicinal Chemistry·John ReganCarol Torcellini
Jan 7, 2003·In Vitro Cellular & Developmental Biology. Animal·Michael J CampbellLaura J Esserman
Jan 28, 2003·Drug Discovery Today·Paul BerozaGraeme R Martin
Jul 19, 2003·The Journal of Biological Chemistry·Galia BlumAlexander Levitzki
Nov 25, 2003·Cancer Investigation·Steven AverbuchAlan Wakeling
Mar 23, 2004·Pharmaceutical Research·Robert G Strickley
Mar 31, 2004·Cancer Cell·Carlos García-EcheverríaFrancesco Hofmann
May 17, 2005·Current Topics in Medicinal Chemistry·Paul BerozaRobert T Lum

❮ Previous
Next ❯

Citations

Jul 17, 2009·The Journal of Biological Chemistry·Theodore W Small, J Geoffrey Pickering
Nov 19, 2008·Antioxidants & Redox Signaling·George VardatsikosAshok K Srivastava
Jan 16, 2007·Current Opinion in Obstetrics & Gynecology·Xiao-ping Gao, Fang Liu
Sep 16, 2010·Cancer Research·Xiaofeng XiaStephen T C Wong
Dec 23, 2011·Molecular Cancer Therapeutics·Hemant K BidPeter J Houghton
May 9, 2007·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Kiyohiko HatakeYoshinori Ito
Apr 13, 2013·The International Journal of Biochemistry & Cell Biology·María Del Nogal-ÁvilaMaría P Ruiz-Torres
Dec 3, 2010·Reproduction : the Official Journal of the Society for the Study of Fertility·D Claire WathesJoe Patton
Nov 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Lick Pui LaiAndrew P McMahon
Dec 5, 2008·Journal of Medicinal Chemistry·William C DreweStephen Neidle
Aug 26, 2011·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Ariel TroibYael Segev
Aug 21, 2009·The Journal of Thoracic and Cardiovascular Surgery·Vien Khach LaiManuel Galiñanes
Jul 27, 2007·Current Opinion in Chemical Biology·Raushan T Kurmasheva, Peter J Houghton
Dec 14, 2011·Bioorganic & Medicinal Chemistry Letters·Séverine DenoyelleMichael Chorev
Feb 15, 2008·Journal of Combinatorial Chemistry·Nir QvitChaim Gilon
Feb 1, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mohammad M Al-SaneaNesreen Nabil Omar
Feb 19, 2011·The Journal of Biological Chemistry·Manuel Sanchez-AlavezTamas Bartfai
Jul 12, 2014·Arteriosclerosis, Thrombosis, and Vascular Biology·Nadira Y YuldashevaStephen B Wheatcroft
Aug 4, 2006·American Journal of Physiology. Cell Physiology·Rebecca R QuesnellBruce D Schultz
Jun 27, 2019·International Journal of Molecular Sciences·Nadine VewingerClaudia Paret
Jan 13, 2019·Nature Communications·Elisa VergariPatrik Rorsman
Mar 27, 2021·Frontiers in Cell and Developmental Biology·Soudeh Ghafouri-FardMohammad Taheri
Sep 12, 2006·Journal of Combinatorial Chemistry·Marc O AndersonR Kiplin Guy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.